GlobalData on MSN
MHRA outlines upcoming IVD submission shift for clinical trials
From 28 April, IVDs used clinical trials will be subject to an upfront assessment by the MHRA as part of a Clinical Trial of ...
The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional randomized controlled trials (RCTs), computational modeling and simulation (CM&S ...
U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of ...
One of the main challenges for medical device developers is ensuring clinical trials meet the expectations of all regulatory authorities in the regions where they wish to release. This will be a ...
TIGERTRIEVER (TM) 13 is the first device shown to meet safety and effectiveness endpoints for restoring blood flow in smaller but critical areas of the brain, accounting for almost 50% of all ischemic ...
In-home clinical devices are among a number of digital health technologies that are being used to streamline clinical trial processes and enable pharmaceutical companies and contract research ...
Key market opportunities include the growing demand for point-of-care imaging and AI-guided applications, expanding in emergency, primary, and home settings. Strong growth in Asia-Pacific and ...
The National Center for Electron Beam Research and National Nuclear Security Administration will pilot eBeam in medical ...
A new study has found that dissolvable medical devices may leave harmful microplastics in the bloodstream, raising safety ...
A new master research agreement with C3 Medical Device Consulting supports product development, technology innovation, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results